Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2163-2174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 3, 2015-03 ,pp. : 440-444

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 7, 2015-07 ,pp. : 1294-1296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term evidence that a pediatric oncology mentorship program for young investigators is feasible and beneficial in the cooperative group setting: A report from the Children's Oncology Group

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study with Interferon alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Carcinoma. A Trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 412-415

Karger

Access to resources Recommend Favorite